Pharmaceuticals in Japan
Pharmaceuticals in Japan
SUMMARY
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Japanese pharmaceuticals market had total revenues of $59,300.0m in 2019, representing a compound annual rate of change (CARC) of -3.1% between 2015 and 2019.
- The fundamentals of the market - its aging population and focus on innovation - remain strong. However, debate is ongoing about the best, sustainable, way to incentivize pharmaceutical innovation with respect to the price of drugs.
- To promote its domestic industry and attract new companies to the market, it has acted to accelerate the approval of new innovative drugs and eased pharmaceutical regulation.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts
- What was the size of the Japan pharmaceuticals market by value in 2019?
- What will be the size of the Japan pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Japan pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Japan's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Daiichi Sankyo Co Ltd
8.2. Takeda Pharmaceutical Company Limited
8.3. Astellas Pharma Inc.
8.4. Mitsubishi Tanabe Pharma Corporation
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
8 COMPANY PROFILES
8.1. Daiichi Sankyo Co Ltd
8.2. Takeda Pharmaceutical Company Limited
8.3. Astellas Pharma Inc.
8.4. Mitsubishi Tanabe Pharma Corporation
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Japan pharmaceuticals market value: $ billion, 2015-19
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Japan pharmaceuticals market share: % share, by value, 2019
Table 5: Daiichi Sankyo Co Ltd: key facts
Table 6: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 7: Daiichi Sankyo Co Ltd: Key Employees
Table 8: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 9: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 10: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 11: Takeda Pharmaceutical Company Limited: key facts
Table 12: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 13: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 14: Takeda Pharmaceutical Company Limited: Key Employees
Table 15: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Astellas Pharma Inc.: Key Employees Continued
Table 20: Mitsubishi Tanabe Pharma Corporation: key facts
Table 21: Mitsubishi Tanabe Pharma Corporation: Annual Financial Ratios
Table 22: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 23: Japan size of population (million), 2015-19
Table 24: Japan gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Japan gdp (current prices, $ billion), 2015-19
Table 26: Japan inflation, 2015-19
Table 27: Japan consumer price index (absolute), 2015-19
Table 28: Japan exchange rate, 2015-19
Table 1: Japan pharmaceuticals market value: $ billion, 2015-19
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Japan pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Japan pharmaceuticals market share: % share, by value, 2019
Table 5: Daiichi Sankyo Co Ltd: key facts
Table 6: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 7: Daiichi Sankyo Co Ltd: Key Employees
Table 8: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 9: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 10: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 11: Takeda Pharmaceutical Company Limited: key facts
Table 12: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 13: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 14: Takeda Pharmaceutical Company Limited: Key Employees
Table 15: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 16: Astellas Pharma Inc.: key facts
Table 17: Astellas Pharma Inc.: Annual Financial Ratios
Table 18: Astellas Pharma Inc.: Key Employees
Table 19: Astellas Pharma Inc.: Key Employees Continued
Table 20: Mitsubishi Tanabe Pharma Corporation: key facts
Table 21: Mitsubishi Tanabe Pharma Corporation: Annual Financial Ratios
Table 22: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 23: Japan size of population (million), 2015-19
Table 24: Japan gdp (constant 2005 prices, $ billion), 2015-19
Table 25: Japan gdp (current prices, $ billion), 2015-19
Table 26: Japan inflation, 2015-19
Table 27: Japan consumer price index (absolute), 2015-19
Table 28: Japan exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Japan pharmaceuticals market value: $ billion, 2015-19
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2019
Figure 10: Japan pharmaceuticals market share: % share, by value, 2019
Figure 1: Japan pharmaceuticals market value: $ billion, 2015-19
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Japan pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Japan, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Japan, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Japan, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2019
Figure 10: Japan pharmaceuticals market share: % share, by value, 2019
